Dexel Pharma is an international pharmaceutical company that develops, manufactures, and markets modified and immediate release branded and generic tablets and capsules focusing on gastroenterological, cardiovascular, and central nervous system diseases. It has 9 unique drug delivery technologies and 22 patent groups. The company was established in 1968 and markets over 50 branded and generic products in 19 countries. It has state-of-the-art manufacturing facilities in Israel and subsidiaries in the US, UK, and Germany.